Updated
Updated · The Washington Post · Jun 16
Antimicrobial Soaps May Fuel 1-in-6 Drug-Resistant Infections as Studies Show No Benefit Over Plain Soap
Updated
Updated · The Washington Post · Jun 16

Antimicrobial Soaps May Fuel 1-in-6 Drug-Resistant Infections as Studies Show No Benefit Over Plain Soap

1 articles · Updated · The Washington Post · Jun 16

Summary

  • Decades of studies found antimicrobial soaps do not prevent illness better than plain soap and water, despite marketing claims that they kill 99.9% of germs.
  • A 2007 review of 27 studies found triclosan was no more effective than plain soap, while lab evidence showed triclosan-resistant bacteria can also become more resistant to antibiotics.
  • The FDA banned 19 antimicrobial ingredients from home antiseptic washes in 2016, but deferred decisions on benzalkonium chloride, benzethonium chloride and chloroxylenol; more than a third of the U.S. disinfectant market now uses these replacements.
  • WHO says 1 in 6 common bacterial infections are now resistant to standard antibiotics, up 40% from 2018 to 2023, with resistant infections causing about 1 million deaths a year.
  • Public health guidance still favors plain soap and water for routine cleaning, reserving disinfectants for higher-risk situations such as bodily fluids, raw meat contamination or stomach-bug outbreaks.

Insights

Beyond superbugs, what other health risks are hiding in the sanitizers you use every day?
Is your 'germ-killing' soap fueling a superbug crisis projected to be deadlier than cancer?
Regulators banned 19 soap chemicals a decade ago. Why are similar risky ones still being sold?